ExodusPoint Capital Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History
Bought
Maintained
Sold
Other funds holding OACCW
AA
DAM
BGIM
WAM
LA
SCM
ExodusPoint Capital Management's OACCW Position: Q1 2026 in Review
ExodusPoint Capital Management held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q1 2026 at 60,000 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.
ExodusPoint Capital Management first reported a position in OACCW in Q4 2024 and has held it in 6 quarters since. The position peaked at $53K in Q4 2024. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.
- ExodusPoint Capital Management held 60,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $45K as of Q1 2026.
- ExodusPoint Capital Management left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q1 2026.
- Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #1462 holding.
- ExodusPoint Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q4 2024 and has held it in 6 quarters since.
- ExodusPoint Capital Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $53K in Q4 2024.
- 26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.